Published in Atherosclerosis on March 11, 2009
Optimization of suture-free laser-assisted vessel repair by solder-doped electrospun poly(ε-caprolactone) scaffold. Ann Biomed Eng (2010) 0.76
Hemodynamics in Coronary Arterial Tree of Serial Stenoses. PLoS One (2016) 0.75
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med (2003) 7.74
Retracted Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA (2013) 4.88
Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med (2013) 4.62
Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care (2012) 4.50
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet (2004) 3.40
Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med (2003) 2.68
HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2008) 2.52
Renal denervation in moderate to severe CKD. J Am Soc Nephrol (2012) 2.21
Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension (2007) 2.13
Estimation of central aortic blood pressure: a systematic meta-analysis of available techniques. J Hypertens (2014) 2.10
Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation (2009) 2.02
Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res (2011) 2.01
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation (2009) 2.00
Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension (2006) 1.90
Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging (2012) 1.83
Insulin resistance and atherosclerosis. Endocr Rev (2006) 1.81
Retracted Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med (2006) 1.71
Retracted Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA (2007) 1.69
Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res (2008) 1.65
Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int (2011) 1.63
Nonmalignant superior vena cava syndrome: pathophysiology and management. Catheter Cardiovasc Interv (2005) 1.62
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension (2005) 1.60
Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol (2002) 1.58
Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension (2010) 1.58
Pancreas transplantation. Lancet (2009) 1.58
Arterial stiffness and prediction of cardiovascular risk. J Hypertens (2002) 1.57
Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol (2002) 1.57
Retracted Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension (2005) 1.57
Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res (2003) 1.55
Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens (2013) 1.54
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J Am Coll Cardiol (2009) 1.53
Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol (2003) 1.53
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. JACC Cardiovasc Interv (2009) 1.52
Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension (2012) 1.52
Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res (2005) 1.52
Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheter Cardiovasc Interv (2009) 1.51
Age and the treatment gap in the use of statins. Lancet (2003) 1.48
Progress towards a National Cardiac Procedure Database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries. Heart Lung Circ (2010) 1.44
Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease. Atherosclerosis (2004) 1.43
Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: analysis of the Melbourne Interventional Group registry. Eur J Heart Fail (2011) 1.41
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux. Circulation (2009) 1.40
Reducing iodinated contrast volume by manipulating injection pressure during coronary angiography. Catheter Cardiovasc Interv (2014) 1.39
Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromes. Coron Artery Dis (2016) 1.39
Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol (2011) 1.39
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes (2012) 1.38
Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry. Med J Aust (2011) 1.38
Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res (2002) 1.38
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med (2013) 1.36
Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol (2007) 1.31
An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheter Cardiovasc Interv (2007) 1.29
Post cardiac arrest syndrome: a review of therapeutic strategies. Circulation (2011) 1.26
Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol (2009) 1.26
Hospital characteristics are associated with patient outcomes following out-of-hospital cardiac arrest. Heart (2011) 1.25
Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol (2007) 1.25
Effects of breaking up prolonged sitting on skeletal muscle gene expression. J Appl Physiol (1985) (2012) 1.24
Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol (2004) 1.23
High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci U S A (2004) 1.23
Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol (2011) 1.22
Gender differences in artery wall biomechanical properties throughout life. J Hypertens (2011) 1.21
Gender differences in large artery stiffness pre- and post puberty. J Clin Endocrinol Metab (2003) 1.20
The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol (2012) 1.17
Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol (2011) 1.15
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv (2010) 1.14
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci (2007) 1.13
Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res (2006) 1.11
Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol (2011) 1.11
Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol (2007) 1.10
Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. Eur Heart J (2011) 1.10
Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol Genomics (2011) 1.10
Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension. Hypertension (2003) 1.09
Alternating bouts of sitting and standing attenuate postprandial glucose responses. Med Sci Sports Exerc (2014) 1.08
Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension (2005) 1.08
Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res (2008) 1.08
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol (2009) 1.07
Misclassification of studies in 'Brachial artery tonometry and the Popeye phenomenon'. J Hypertens (2013) 1.07
Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension (2008) 1.05
Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. Circulation (2002) 1.05
Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol (2009) 1.03
Accuracy of automated auscultatory blood pressure measurement during supine exercise and treadmill stress electrocardiogram-testing. Blood Press Monit (2004) 1.02
Physical fitness and reverse cholesterol transport. Arterioscler Thromb Vasc Biol (2004) 1.02